Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Toxicology Letters
|
July 30, 2017
An evaluation of myeloperoxidase-mediated bio-activation of NSAIDs in promyelocytic leukemia (HL-60) cells for potential cytotoxic selectivity
Andrew G M Morgan, Dinesh Babu, Karim Michail, et al.
Immunogenetics
|
January 1, 1980
High titres of antibody to murine leukaemia virus in lymphocyte (Ly) alloantisera
W Y Langdon, G R Shellam, G M Morgan, et al.
Transplantation
|
August 1, 1978
Detection of mouse alloantibodies by rosetting with protein A-coated sheep red blood cells
M S Sandrin, T A Potter, G M Morgan, et al.
Immunogenetics
|
January 1, 1980
Studies of two H-2Db mutants: B6. C-H-2bm13 and B6.C-H-2bm14
G M Morgan, H Dellos, I F McKenzie, et al.
Chemico-Biological Interactions
|
December 15, 2015
Cytoprotective effect of isoniazid against H2O2 derived injury in HL-60 cells
Saifur R Khan, Naif Aljuhani, Andrew G M Morgan, et al.
The Journal of Experimental Medicine
|
December 1, 1979
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse
I F McKenzie, G M Morgan, M S Sandrin, et al.
Biochemical Pharmacology
|
February 13, 2016
Metabolism of isoniazid by neutrophil myeloperoxidase leads to isoniazid-NAD(+) adduct formation: A comparison of the reactivity of isoniazid with its known human metabolites
Saifur R Khan, Andrew G M Morgan, Karim Michail, et al.
Epidemiology and Infection
|
August 1, 1988
First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK
G M Morgan, C Newman, S R Palmer, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Toxicology Letters
|
July 30, 2017
An evaluation of myeloperoxidase-mediated bio-activation of NSAIDs in promyelocytic leukemia (HL-60) cells for potential cytotoxic selectivity
Andrew G M Morgan, Dinesh Babu, Karim Michail, et al.
Immunogenetics
|
January 1, 1980
High titres of antibody to murine leukaemia virus in lymphocyte (Ly) alloantisera
W Y Langdon, G R Shellam, G M Morgan, et al.
Transplantation
|
August 1, 1978
Detection of mouse alloantibodies by rosetting with protein A-coated sheep red blood cells
M S Sandrin, T A Potter, G M Morgan, et al.
Immunogenetics
|
January 1, 1980
Studies of two H-2Db mutants: B6. C-H-2bm13 and B6.C-H-2bm14
G M Morgan, H Dellos, I F McKenzie, et al.
Chemico-Biological Interactions
|
December 15, 2015
Cytoprotective effect of isoniazid against H2O2 derived injury in HL-60 cells
Saifur R Khan, Naif Aljuhani, Andrew G M Morgan, et al.
The Journal of Experimental Medicine
|
December 1, 1979
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse
I F McKenzie, G M Morgan, M S Sandrin, et al.
Biochemical Pharmacology
|
February 13, 2016
Metabolism of isoniazid by neutrophil myeloperoxidase leads to isoniazid-NAD(+) adduct formation: A comparison of the reactivity of isoniazid with its known human metabolites
Saifur R Khan, Andrew G M Morgan, Karim Michail, et al.
Epidemiology and Infection
|
August 1, 1988
First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK
G M Morgan, C Newman, S R Palmer, et al.
Page
of 2